A Comparative Clinical Trial to Evaluate the Efficacy of Shatapushpa Taila and Lashuna Taila Nasya on Abeejotsarga With Special Reference to Anovulation – An Open-Label Randomized Controlled Trial.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Induction of Ovulation: Improvement in follicular development and ovulation as assessed by ultrasonography.
研究概览
简要总结
Title:****“A COMPARATIVE CLINICAL TRIAL TO EVALUATE EFFICACY OF SHATAPUSHPA TAILA AND LASHUNA TAILA NASYA ON ABEEJOTSARGA W.S.R TO AN-OVULATION” – AN OPEN LABEL RANDOMISED CONTROLLED TRIAL.
Infertility, particularly an-ovulation, is a significant concern affecting approximately 30% of infertility cases. Ayurveda offers a holistic approach to managing an-ovulation through Nasya therapy.
This randomized controlled trial aims to evaluate the efficacy of Shatapushpa Taila Nasya and Lashuna Taila Nasya in promoting ovulation.
Shatapushpa (Anethum sowa) is known for its Beejotsarga and Artavajanana properties, aiding in follicular development and hormonal balance. Lashuna (Allium sativum) is described as a potent fertility enhancer that regulates hormonal imbalances and supports oogenesis. Since Nasya (nasal administration) directly influences the brain and hormonal pathways, it is expected to play a vital role in restoring ovulatory functions.
This open-label randomized controlled trial will assess the impact of these Ayurvedic interventions on ovulation, providing a cost-effective, safe, and natural alternative for infertility management.
Assessment will be done on the basis of subjective and objective criteria and investigations.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Open Label
入排标准
- 年龄范围
- 20.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •Primary and secondary infertility Complain of an-ovulatory factors The patients of child bearing age.
排除标准
- •Reproductive tract tuberculosis, carcinoma, Congenital deformities Chronic illness, Cardiac diseases, Thyroid disorders, Tubal blockage, uterine factors, •Patient not suitable for nasya.
结局指标
主要结局
Induction of Ovulation: Improvement in follicular development and ovulation as assessed by ultrasonography.
时间窗: 7 days
Hormonal Balance: Regulation of LH, FSH, and estrogen-progesterone levels.
时间窗: 7 days
Menstrual Regularity: Improvement in cycle length, flow, and reduction of oligomenorrhea/amenorrhea.
时间窗: 7 days
次要结局
- Improvement in general well-being(Nasya-specific benefits)